A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma
Phase of Trial: Phase III
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Benralizumab (Primary) ; Influenza virus vaccine
- Indications Asthma
- Focus Pharmacodynamics; Registrational
- Acronyms ALIZE
- Sponsors AstraZeneca
- 19 Jan 2017 Status changed from active, no longer recruiting to completed.
- 29 Nov 2016 Planned End Date changed from 1 Feb 2017 to 1 Jan 2017.
- 29 Nov 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Jan 2017.